BESREMI

Pharmaceutical preparations; antineoplastic and immunomodulating agents; pharmaceutical preparations containing ropeginterferon alfa-2b for the treatment of viral infections, cancers, or Essential thrombocythemia (ET); medicines for human purposes for treating viral infections, cancers, or ET; chemical-pharmaceutical preparations containing ropeginterferon alfa-2b for treating viral infections, cancers, or ET.